Top of this page
Skip navigation, go straight to the content

UCB medicines are making a difference in the lives of people all over the world.

Select U.S. Products

Cimzia® in the U.S.

Cimzia®(certolizumab pegol) is indicated for the treatment of adult patients suffering from moderately to severely active rheumatoid arthritis.

Cimzia®(certolizumab pegol) is indicated for the treatment of adult patients with active psoriatic arthritis (PsA) and for the treatment of adults with active ankylosing spondylitis (AS) as well.

Cimzia® (certolizumab pegol) is also indicated for reducing signs and symptoms of Crohn's disease and maintaining clinical response in adult patients with moderately to severely active disease who have had an inadequate response to conventional therapy. Consult www.cimzia.com for full prescribing information.

Vimpat® in the U.S.

Vimpat®(lacosamide) C-Ⅴ is indicated in patients 17 years of age and older with partial-onset seizures as monotherapy or adjunctive therapy.

Vimpat® (lacosamide) C-Ⅴ injection for intravenous use is an alternative when oral administration is not feasible. Consult www.vimpat.com for full prescribing information.

Neupro® in the U.S.

Neupro®(Rotigotine Transdermal System) is indicated for the treatment of signs and symptoms of idiopathic Parkinson's disease.

Neupro® (Rotigotine Transdermal System) is also indicated for the treatment of moderate-to-severe primary Restless Legs Syndrome. Consult www.neupro.com for full prescribing information.

Keppra XR® in the U.S.

Keppra XR®(levetiracetam) extended-release tablets are indicated as adjunctive therapy in the treatment of partial-onset seizures in patients 16 years of age and older with epilepsy.
Consult www.keppraXR.com for full prescribing information for Keppra XR and Keppra®.

Metadate CD® in the U.S.

Metadate CD®(methylphenidate HCl, USP) Extended Release capsules, CII are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). Click here for full prescribing information.

Tussionex®

Pennkinetic® in the U.S.

Tussionex® Pennkinetic® (hydrocodone polistirex and chlorpheniramine polistirex) Extended-Release Suspension, CII is indicated for relief of cough and upper respiratory symptoms associated with allergy or a cold in adults and children 6 years of age and older. Click here for full prescribing information.

Cimzia®, Keppra XR®, Keppra®, Neupro®, Metadate CD® and Tussionex® Pennkinetic® are trademarks of the UCB Group of Companies.

Vimpat® is a registered trademark under license from Harris FRC Corporation.

Please note

For additional information on other products not listed here, contact UCB Medical Information at +1.877.822.9493.